Skip to main content


Log in

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

  • International Forum 2
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript


The “Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC),” the first evidence-based guidelines for the treatment of HCC in Japan, were compiled by an expert panel supported by the Japanese Ministry of Health, Labour, and Welfare. The English translation has been completed (, and its summary has just been published (Hepatol Res 38:37–51, 2008). This set of guidelines covers six research fields: prevention, diagnosis and surveillance, surgery, chemotherapy, transarterial chemoembolization, and percutaneous local ablation therapy. For the users’ convenience, practical algorithms for the surveillance and treatment of HCC were also created, which are based on evidence from articles selected for the guidelines and modified according to the current status of medical practice in Japan. One year after their publication, the J-HCC Guidelines have become well disseminated among both specialists and primary care physicians in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision making for HCC. The first revision of the J-HCC Guidelines is now in process, and it is scheduled to be completed by March 2009.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Ryder SD. Guidelines for the diagnosis and treatment of hepato-cellular carcinoma (HCC) in adults. Gut 2003;52(suppl III):iii1–iii8.

    PubMed  Google Scholar 

  2. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19(3):329–338.

    Article  PubMed  CAS  Google Scholar 

  3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421–430.

    Article  PubMed  CAS  Google Scholar 

  4. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 2002;235(4):466–486.

    Article  PubMed  Google Scholar 

  5. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol 2006;12(5):828–829.

    PubMed  Google Scholar 

  6. Group formed to establish “Guidelines for evidence-based clinical practice for the treatment of liver cancer.” Clinical practice guidelines for hepatocellular carcinoma (in Japanese). Tokyo: Kanehara; 2005.

    Google Scholar 

  7. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara; 2003.

    Google Scholar 

  8. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.

    Article  PubMed  CAS  Google Scholar 

  9. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Multiple tumors and concomitant portal hypertension are not operative contraindications for hepatocellular carcinoma. Gastroenterology 2008;134:1908–1916.

    Article  PubMed  Google Scholar 

  10. Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008;38:37–51.

    Article  PubMed  Google Scholar 

  11. Kokudo N, Sasaki Y, Nakayama T, Makuuchi M. Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons, and primary care physicians. Gut 2007;56(7):1020–1021.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Kokudo, N., Makuuchi, M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 44 (Suppl 19), 119–121 (2009).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Key words